In the scenario of malignant hyperthermia, which medication is essential to treat the condition?

• A. Dantrolene sodium
• B. Epinephrine
• C. Morphine
• D. Insulin

Answer: (A)

Treating a malignant hyperthermia crisis centers on dantrolene sodium, the drug that directly reduces the abnormal calcium release from the skeletal muscle's sarcoplasmic reticulum. In MH, triggering anesthetics cause the ryanodine receptor to release calcium uncontrollably, driving extreme muscle contraction, rapid metabolism, heat production, acidosis, and fever. Dantrolene interrupts this process by inhibiting calcium release, slowing down muscle activity and halting the hypermetabolic cascade. This makes it the essential treatment. Alongside stopping triggering agents, provide 100% oxygen, start aggressive cooling, and manage fluids and electrolytes while monitoring for complications. The usual initial dose is about 2.5 mg/kg IV, with additional dosing as needed up to higher total amounts based on response. Other drugs like epinephrine, morphine, or insulin do not address the calcium dysregulation at the heart of MH and are not appropriate primary treatments.